LEBLANC, R.; HOLLMANN, S.; TAY, J. CANADIAN COST ANALYSIS COMPARING MAINTENANCE THERAPY WITH BORTEZOMIB VERSUS LENALIDOMIDE FOR PATIENTS WITH MULTIPLE MYELOMA POST AUTOLOGOUS STEM CELL TRANSPLANT. Journal of Population Therapeutics and Clinical Pharmacology, [S. l.], v. 23, n. 1, 2018. Disponível em: https://jptcp.com/index.php/jptcp/article/view/237. Acesso em: 8 aug. 2022.